Showing results (91-100 of 260) with videos related to
Sort By:
Pageof 26
Cancer Treatment Reports|April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicinP Hurteloup, P Cappelaere, J P Armand, et al.Cellular Immunology|October 15, 1983
Reversal of immunological tolerance by aclacinomycin through inhibition of suppressor cell activityS Orbach-Arbouys, C E Andrade-Mena, G MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Hematon: a multicellular functional unit in primary hematopoiesisI Blazsek, J L Misset, M Comisso, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2002
I. ArginineH Tapiero, G Mathé, P Couvreur, et al.International Archives of Allergy and Applied Immunology|January 1, 1985
Enhancement of immune responses in tumor-bearing mice after administration of cis-diamino-dichloro-platinum (II)C E Andrade Mena, S Orbach-Arbouys, G MathéAnticancer Research|November 1, 1983
Difference between monoclonal antibodies against the common acute leukemia antigen from two different hybridomasC Canon, F Eichler-Reiss, P Reizenstein, et al.Oncology|January 1, 1986
Phase I study of cis-dichloro-trans-dihydroxy-bis(isopropylamine)platinum IV (CHIP)P Ribaud, J Gouveia, J L Misset, et al.Immunopharmacology|August 1, 1985
Immunological effect of cycloheximide in miceC E Andrade-Mena, S Orbach-Arbouys, G MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
The in vivo effect of ellipticine analogues on the blood concentration of Friend virus: a murine model for studying anti-HIV drugsG Mathé, E Chenu, C Bourut, et al.The British Journal of Cancer. Supplement|March 1, 1975
Cytology in the classification of diffuse non-leukaemic malignant lymphomata (lympho- and reticulosarcomata)G Mathé, P Pouillart, J R Schlumberger, et al.Pageof 26